For this, we compared anti-DSG3 ALBIA performed with anti-DSG3 Abs containing sera from 65 PV patients with 56 control sera (36 HD, 6 PF, 5 PV with negative anti-DSG3 Abs after RTX treatment, and 9 BP). The gene discussed is DSG3; the disease is acquired polycythemia vera.